Fifteen years' experience with this “new” multisystem disease of very young children has led to a broader understanding of its clinical behavior, pathology, epidemiology, and spectrum of associated cardiovascular complications, including fatal myocardial infarction. Long-term follow-up of a large number of survivors has yielded unexpected findings of significant residual sequelae.
No takes yet. Share an insight, caveat, or question.
Melish et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: